Source: Health Canada shortage reports · Updated Jul 21, 2026
Also sold as: Hulio, Abrilada, Humira
Some Adalimumab products are in shortage in Canada (1 of 7 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An anti-TNF biologic used to treat autoimmune conditions such as arthritis and Crohn's disease.
Products affected
1 / 7
Reports on file
11
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ABRILADA
20MG · SOLUTION · PFIZER CANADA ULC
DIN 02511061 · since ?, no end estimate · Disruption of the manufacture of the drug.
To be discontinued
HUMIRA
40MG · SOLUTION · ABBVIE CORPORATION
DIN 02258595
Resolved
ABRILADA
40MG · SOLUTION · PFIZER CANADA ULC
DIN 02511045 · ended Nov 14, 2025 · Disruption of the manufacture of the drug.
Resolved
HULIO
40MG · SOLUTION · BGP PHARMA ULC
DIN 02502402 · ended Feb 1, 2023 · Disruption of the manufacture of the drug.
Resolved
HULIO
40MG · SOLUTION · BGP PHARMA ULC
DIN 02502399 · ended Jan 19, 2023 · Disruption of the manufacture of the drug.
Avoided
ABRILADA
40MG · SOLUTION · PFIZER CANADA ULC
DIN 02511053 · ended Dec 7, 2022 · Disruption of the manufacture of the drug.
Resolved
HULIO
20MG · SOLUTION · BGP PHARMA ULC
DIN 02502380 · ended Dec 7, 2022 · Disruption of the manufacture of the drug.
Resolved
HULIO
40MG · SOLUTION · BGP PHARMA ULC
DIN 02502402 · ended Nov 21, 2022 · Disruption of the manufacture of the drug.
Resolved
HULIO
40MG · SOLUTION · BGP PHARMA ULC
DIN 02502399 · ended Nov 9, 2022 · Disruption of the manufacture of the drug.
Resolved
HULIO
40MG · SOLUTION · BGP PHARMA ULC
DIN 02502402 · ended Oct 21, 2022 · Disruption of the manufacture of the drug.
Discontinued
HUMIRA VIAL
40MG · SOLUTION · ABBVIE CORPORATION
DIN 02258595
What's happening
Adalimumab is currently affected by an active shortage report filed with Health Canada by PFIZER CANADA ULC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Adalimumab is classified under “IMMUNOSUPPRESSANTS” (ATC L04AB).
Recent changes
No changes recorded yet.
Common questions
What is Adalimumab used for?
An anti-TNF biologic used to treat autoimmune conditions such as arthritis and Crohn's disease.
When will Adalimumab be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Adalimumab in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.